EVM
ANIK icon

Eaton Vance Management’s Anika Therapeutics ANIK Stock Holding History

Eaton Vance Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-217
Closed -$8K – 1845
2021
Q4 		$8K Sell
217
-8
-4% -$320 ﹤0.01% 2566
2021
Q3 		$0 Sell
225
-109
-33% -$4.49K ﹤0.01% 2015
2021
Q2 		$15K Buy
334
+269
+414% +$11.5K ﹤0.01% 2476
2021
Q1 		$3K Sell
65
-5,290
-99% -$201K ﹤0.01% 2688
2020
Q4 		$242K Buy
+5,355
New +$203K ﹤0.01% 1378
2018
Q4 		– Sell
-5,732
Closed -$242K – 1176
2018
Q3 		$242K Buy
+5,732
New +$226K ﹤0.01% 1154
2018
Q2 		– Sell
-5,732
Closed -$285K – 1173
2018
Q1 		$285K Hold
5,732
– – ﹤0.01% 1041
2017
Q4 		$309K Buy
5,732
+4
+0.1% +$221 ﹤0.01% 1046
2017
Q3 		$332K Buy
5,728
+2
+0% +$105 ﹤0.01% 1012
2017
Q2 		$283K Buy
5,726
+8
+0.1% +$368 ﹤0.01% 1015
2017
Q1 		$248K Sell
5,718
-295
-5% -$14.1K ﹤0.01% 993
2016
Q4 		$294K Hold
6,013
– – ﹤0.01% 941
2016
Q3 		$288K Hold
6,013
– – ﹤0.01% 920
2016
Q2 		$323K Sell
6,013
-2,000
-25% -$94.2K ﹤0.01% 878
2016
Q1 		$358K Hold
8,013
– – ﹤0.01% 842
2015
Q4 		$306K Sell
8,013
-2,002
-20% -$76.6K ﹤0.01% 868
2015
Q3 		$319K Hold
10,015
– – ﹤0.01% 852
2015
Q2 		$331K Hold
10,015
– – ﹤0.01% 828
2015
Q1 		$412K Buy
+10,015
New +$405K ﹤0.01% 825

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Eaton Vance Management's ANIK Position: Q1 2022 in Review

Eaton Vance Management sold out of Anika Therapeutics (ANIK) in Q1 2022, closing a stake of 217 shares — an estimated $8K sold.

Eaton Vance Management first reported a position in ANIK in Q1 2015 and held it in 19 quarters. The position peaked at $412K in Q1 2015. 118 funds tracked by Wall St. Rank hold ANIK as of Q1 2022.

  • Eaton Vance Management reported no remaining Anika Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 217 Anika Therapeutics shares in Q1 2022, an estimated $8K.
  • Eaton Vance Management first reported a position in Anika Therapeutics in Q1 2015 and held it in 19 quarters.
  • Eaton Vance Management's Anika Therapeutics position peaked at $412K in Q1 2015.
  • 118 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.